A Targetable Cue In T-Cell Malignancy

BLOOD(2020)

引用 1|浏览11
暂无评分
摘要
In this issue of Blood, De Smedt et al demonstrate that glucocorticoid treatment of a subset of T-cell acute lymphoblastic leukemia/T-cell acute lymphoblastic lymphoma (T-ALL/T-LBL) cells upregulates PIM1 expression, creating a synergistic vulnerability and potent antileukemic effect with PIM1 inhibitors in a preclinical model.(1)
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要